HPLC determination of tritiated polycyclic aromatic hydrocarbon metabolites in the subfemtomole range

Toxicology Methods

Volumn 8, Issue 1, 1998, Pages 17-25

  Scott, Gary G ^a   Stephens, John A ^a   Rohrbacher, Kevin D ^b   Thornton Manning, Janice R ^b   Gerde, Per ^c   Dahl, Alan R ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b PFIZER INC   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

BaP; Metabolism; PAHs; Pyrene; Radiometric analysis

Indexed keywords

ACETIC ACID ETHYL ESTER; BENZO[A]PYRENE; CALCIUM OXIDE; DRUG METABOLITE; LIPID; METHANOL; POLYCYCLIC AROMATIC HYDROCARBON; PYRENE; TRITIUM OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD; DOG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID SCINTILLATION COUNTING; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RADIOMETRY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

CANIS FAMILIARIS;

EID: 0031657277     PISSN: 10517235     EISSN: None     Source Type: Journal    
DOI: 10.1080/105172398243005     Document Type: Article

References (21)

1. Madhavan ND, Naidu KA. Polycycyclic aromatic hydrocarbons in placenta, maternal blood, umbilical cord blood and milk of Indian women. Hum Exp Toxicol. 1995;14:503-506.
2. Alexandrov K, Rojas M, Golberg M, Camus AM, Bartsch H. A new sensitive fluorometric assay for the metabolism of (-)-7-8,-dihydroxy-7,8,-dihydrobenzo[a]pyrene by human hair follicles. Carcinogenesis. 1990;11:2157-2161.
3. Likhachev AJ, Beniashvili DA, Bykov VJ, et al. Biomarkers for individual susceptibility to carcinogenic agents: excretion and carcinogenic risk of benzo[a]pyrene metabolites. Environ Health Perspect. 1992;98:211-214.
4. Saito Y, Sekita H, Takeda M, Uchiyama M. Determination of benzo[a]pyrene in foods. J Assoc Anal Chem. 1978;61:129-135.
5. Gomes M, Santella RM. Immunologic methods for detection of benzo[a]pyrene metabolites in urine. Chem Res Toxicol. 1990;3:307-310.
6. Weston A, Bowman ED, Carr P, Rothman N, Strickland PT. Detection of metabolites of polycyclic aromatic hydrocarbons in human urine. Carcinogenesis. 1993;14:1053-1055.
7. Strickland PT, Kang D, Bowman ED, et al. Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. Carcinogenesis. 1994;15:483-487.
8. Hansen AM, Poulsen OM, Christensen JM. Determination of 1-hydroxypyrene in human urine by high-performance liquid chromatography. J Anal Toxicol. 1993;17:38-41.
9. Jongeneelen FJ, Anzion RBM, Henderson PT. Determination of hydroxylated metabolites of polycyclic hydrocarbons in urine. J Chromatogr. 1987;413:227-232.
10. Lintelmann J, Hellemann C, Kettrup A. Coupled-column high-performance liquid chromatographic method for the determination of four metabolites of polycyclic aromatic hydrocarbons, 1-, 4-, and 9-hydroxyphenanthrene and 1-hydroxypyrene, in urine. J Chromatog. 1994;660:67-73.
11. Gerde P, Muggenburg BA, Thornton-Manning JR, Lewis JL, Pyon KH, Dahl AR. Benzo[a]-pyrene at an environmentally relevant dose is slowly absorbed by and extensively metabolized in tracheal epithelium. Carcinogenesis. 1997;18:1825-1832.
12. Dahl AR, Benson JM, Hanson RL, Rothenberg SJ. The fractionation of environmental samples according to volatility by vacuum line-cryogenic distillation. Am Ind Hyg Assoc J. 1984;45:193-198.
13. Aarstad K, Toftgard R, Nilsen OG. A comparison of the binding and distribution of benzo[a]-pyrene in human and rat serum. Toxicology. 1987;47:235-245.
14. Van de Wiel JAG, Fijneman PHS, Duijf CMP, Anzion RBM, Theuws JLG, Bos RP. Excretion of benzo[a]pyrene and metabolites in urine and feces of rats: influence of route of administration, sex and long-term ethanol treatment. Toxicology. 1993;80:103-115.
15. Uziel M, Haglund R. Persistence of benzo[a]pyrene and 7,8-dihydro-7,8-dihydroxybenzo[a]-pyrene in Fischer F344 rats: time distribution of total metabolites in blood, urine, and feces. Carcinogenesis. 1988;9:233-238.
16. Mitchell CE. The metabolic fate of benzo[a]pyrene in rats after inhalation. Toxicology. 1983;28: 65-73.
17. Weyand EH, Bevan DR. Benzo[a]pyrene disposition and metabolism in rats following intratracheal instillation. Cancer Res. 1986;46:5655-5661.
18. Foth H, Kahl R, Kahl GF. Pharmacokinetics of low doses of benzo[a]pyrene in the rat. Fed Chem Toxicol. 1988;26:45-51.
19. Bevan DR, Ulman MR. Examination of factors that may influence disposition of benzo[a]pyrene in vivo: vehicles and asbestos. Cancer Lett. 1991;57:173-179.
20. Bevan DR, Sadler VM. Quinol diglucuronides are predominant conjugated metabolites found in bile of rats following intratracheal instillation of benzo[a]pyrene. Carcinogenesis. 1992;13:403-407.
21. Withey J, Shedden J, Law FCP, Abedini S. Distribution of benzo[a]pyrene in pregnant rats following inhalation exposure and a comparison with similar data obtained with pyrene. J Appl Toxicol. 1993;13:193-202.